Ropes & Gray advised ImmunoGen on the deal.ImmunoGen, a leader in the field of antibody-drug conjugates for the treatment of cancer, announced a global, multi-year licensing…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now